Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH · BSE: 532989 · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹350.05
Market cap: ₹828.1 Cr
Revenue (annual): ₹150.6 Cr
Net profit (annual): ₹11.10 Cr
P/E (TTM): 106.4×Sector 50.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Aug 2026 17:51 IST BSE

Financial Results

Bafna Pharmaceuticals Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 97.1% YoY

Bafna Pharmaceuticals Ltd reported revenue from operations of ₹26.6 Cr (-23.1% YoY) and net profit of ₹0.1 Cr (-97.1% YoY) for Q1 FY27.

Key figure: Net profit ₹0.1 Cr · -97.1% YoY

Open full results → Read the filing ↗

29 May 2026 18:32 IST NSE

Financial Results

Bafna Pharmaceuticals Q4 FY26 Results: Net Profit ₹2.7 Cr, Up 107.7% YoY

Bafna Pharmaceuticals Ltd reported revenue from operations of ₹42.2 Cr (+7.9% YoY) and net profit of ₹2.7 Cr (+107.7% YoY) for Q4 FY26.

Key figure: Net profit ₹2.7 Cr · +107.7% YoY

Open full results → Read the filing ↗